Book chapter
Head and Neck Tumors
Molecular Oncology Testing for Solid Tumors, pp.303-339
Springer International Publishing
08/18/2015
DOI: 10.1007/978-3-319-16304-8_16
Abstract
Molecular testing for head and neck squamous mucosal lesions and salivary gland tumors is becoming part of routine practice. Viral oncogenesis is implicated in both head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Human papillomavirus (HPV) is detected in a majority of oropharyngeal squamous cell carcinomas and is associated with improved response to treatment. Detection of Epstein Barr Virus (EBV) in nasopharyngeal carcinoma is diagnostically useful. For salivary gland tumors, characteristic translocations with resultant fusion oncogenes have been identified. These genetic rearrangements can be detected by fluorescence in situ hybridization (FISH) testing and have diagnostic utility. These oncogenes also provide hope as therapeutic targets. ERBB2 (HER2) is one therapeutic target that has a role in salivary duct carcinoma. A subset of this tumor overexpresses ERBB2, and stabilization of disease has been reported with trastuzumab therapy.
Details
- Title: Subtitle
- Head and Neck Tumors
- Creators
- Jennifer LaudadioAnthony N Snow - University of Iowa, Pathology
- Contributors
- Michael Ola Idowu (Editor)Catherine Isabelle Dumur (Editor)Carleton Theodore Garrett (Editor)
- Resource Type
- Book chapter
- Publication Details
- Molecular Oncology Testing for Solid Tumors, pp.303-339
- DOI
- 10.1007/978-3-319-16304-8_16
- Publisher
- Springer International Publishing; Cham
- Language
- English
- Date published
- 08/18/2015
- Academic Unit
- Pathology
- Record Identifier
- 9984051400302771
Metrics
15 Record Views